Pharmacy Practice
Monitoring Chemotherapy in an Aging Population
By Judith A. Smith, Pharm.D, BCOP
Breast Imaging: Economic Issues and Challenges
By Dione M. Farria, MD, MPH, and Stephen A. Feig, MD
A Systematic Approach to Improving Care for Cancer Patients: Focus on Growth Factor Use and Outcomes
By Kimberly A. Bergstrom, PharmD, and Eric T. Herfindal, PharmD, MPH
Letter From the Editors
Are We Prepared for the Genomics Era?
By J. Lyle Bootma
The Genetics of Multiple Myeloma
By Brian Van Ness, PhD
Diagnosis and Treatment of Depression in the Cancer Patient
Tracy L. Skaer, PharmD, Linda M. Robison, MSPH, David A. Sclar, PhD
High-Dose Therapy in Patients with Multiple Myeloma
By Bhawna Sirohi, MBBS, DCH and Ray Powles, MD, MRCP, MRCPath
Pharmacology and Therapeutic Use of Trastuzumab in Breast Cancer
By Imad Treish, PharmD, Rowena Schwartz, PharmD, BCOP, and Celeste Lindley, PharmD, BCPS, FASHP, FCCP
Guest Editor
Research Needs in Myeloma
Gregory R. Mundy, MD
Colorectal Cancer Screening: How Are We Doing and How Can We Improve?
Virender K. Sharma, MD, and Colin W. Howden, MD
Increased Mortality Risk Associated With Medial Breast Tumors May Be Due to Untreated Internal Mammary Node Metastases
Caroline Lohrisch, MD
Pharmacoeconomics of Cisplatin-Based Chemoradiation in Cervical Cancer: A Review
Peter G. Rose, MD, and Panos T. Lappas
New Medicines in Development for Cancer
Pharmaceutical Research and Manufacturers of America (PhRMA)
Publisher’s Statement
Raising Cain
James M. La Rossa Jr.
A Singleness of Purpose— A Spectrum of Expertise and Care— What Will the Future Bring?
J. Lyle Bootman, PhD Co-Editor
Daniel D. Von Hoff, MD Co-Editor